PMLS Virtual Series 2021 – Pharmacogenomics

On Demand Now Click Here

Oct 19, 2021

Kristine Ashcraft, MBA

Medical Affairs Director, Pharmacogenomics, Invitae

Burns C. Blaxall, PhD, FACC, FAHA, FISHR, FAPS

Executive Director, Precision Medicine, The Christ Hospital Health Network

Katherine Capps

Co-founder and Executive Director, GTMRx

Julie Ceno-England, MD

Head, Medical Affairs; Interim Chief Medical Officer, OneOme

Martin Dawes, MD

Co-Founder and Chief Scientific Officer, GenXys Health Care Systems

Ghada Elnashar, PharmD, MS

Medical Liaison, OneOme

Bernard Esquivel, MD, PhD, MHA

Chief Medical Officer, GenXys Health Care Systems

Jennifer Hockings, PharmD, PhD

Pharmacogenomics Clinical Specialist at Cleveland Clinic in the Department of Pharmacy and Center for Personalized Genetic Healthcare (CPGH)

Pashtoon Kasi, MD, MS

Director Colon Cancer Research, Weill Cornell Medicine; Precision Medicine Director for Liquid Biopsy Research, Englander Institute of Precision Medicine

Adrijana Kekic, PharmD

Pharmacogenomics Clinical Pharmacy Specialist, Assistant Program Director (APD), Community-Based Pharmacy Residency; APD Outpatient Pharmacy Education, Mayo Clinic, Arizona (MCA)

Howard McLeod, PharmD, FASCO, FCCP

Medical Director, Geriatric Oncology Consortium and Professor, University of South Florida

Anthony P. Morreale, PharmD, MBA, BCPS, FASHP

Associate Chief Consultant, Clinical Pharmacy and Policy, Department of Veterans Affairs Pharmacy Benefits Management, VA Central Office

Latha Palaniappan, MD, MS

Professor, Stanford University School of Medicine

Elvin Price, PharmD, PhD

Victor A. Yanchick Associate Professor and Director of the Geriatric Pharmacotherapy at the Virginia Commonwealth University School of Pharmacy and Co-Director of the Institute for Inclusion, Inquiry and Innovation (iCubed) Health and Wellness in Aging Core

Kandace Schuft, PharmD

Senior Clinical Content Specialist, Pharmacogenomics, Wolters Kluwer

David Stenehjem, PharmD, BCOP

Associate Professor, Associate Department Head, Department of Pharmacy Practice & Pharmaceutical Sciences, University of Minnesota, College of Pharmacy

Jacques Turgeon, BPharm, PhD

Chief Scientific Officer and Chief Executive Officer, TRHC Precision Pharmacotherapy, Research and Development Institute